<VariationArchive VariationID="225508" VariationName="NM_003331.5(TYK2):c.209_212del (p.Cys70fs)" VariationType="Deletion" Accession="VCV000225508" Version="4" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-02-20" DateCreated="2015-10-11" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="227400" VariationID="225508">
      <GeneList>
        <Gene Symbol="TYK2" FullName="tyrosine kinase 2" GeneID="7297" HGNC_ID="HGNC:12440" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19p13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="10350533" stop="10380572" display_start="10350533" display_stop="10380572" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="10461203" stop="10491247" display_start="10461203" display_stop="10491247" Strand="-" />
          </Location>
          <OMIM>176941</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_003331.5(TYK2):c.209_212del (p.Cys70fs)</Name>
      <CanonicalSPDI>NC_000019.10:10368399:AAGCAAG:AAG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>19p13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="10368400" stop="10368403" display_start="10368400" display_stop="10368403" variantLength="4" positionVCF="10368399" referenceAlleleVCF="GAAGC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="10479076" stop="10479079" display_start="10479076" display_stop="10479079" variantLength="4" positionVCF="10479075" referenceAlleleVCF="GAAGC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>C70fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_121t1" sequenceAccession="LRG_121t1" change="c.209_212del">
            <Expression>LRG_121t1:c.209_212del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_121" sequenceAccession="LRG_121" change="g.17170_17173del">
            <Expression>LRG_121:g.17170_17173del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.10368403_10368406del" Assembly="GRCh38">
            <Expression>NC_000019.10:g.10368403_10368406del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.10479079_10479082del" Assembly="GRCh37">
            <Expression>NC_000019.9:g.10479079_10479082del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007872.1" sequenceAccession="NG_007872" sequenceVersion="1" change="g.17170_17173del">
            <Expression>NG_007872.1:g.17170_17173del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003331.5" sequenceAccession="NM_003331" sequenceVersion="5" change="c.209_212del" MANESelect="true">
            <Expression>NM_003331.5:c.209_212del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003322.3" sequenceAccession="NP_003322" sequenceVersion="3" change="p.Cys70fs">
            <Expression>NP_003322.3:p.Cys70fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA9193810" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="176941.0001" DB="OMIM" />
        <XRef Type="rs" ID="770927552" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003331.5(TYK2):c.209_212del (p.Cys70fs) AND Immunodeficiency 35" Accession="RCV000014228" Version="28">
        <ClassifiedConditionList TraitSetID="3648">
          <ClassifiedCondition DB="MedGen" ID="C1969086">Immunodeficiency 35</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-11-27" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003331.5(TYK2):c.209_212del (p.Cys70fs) AND not provided" Accession="RCV000519417" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-10-30" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-27" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2015-10-11" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">17088085</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22402565</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26304966</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29725107</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3648" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5079" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">TYK2 DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="611521" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Immunodeficiency 35</ElementValue>
                <XRef ID="MONDO:0012682" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tyrosine kinase 2 deficiency</ElementValue>
                <XRef ID="Tyrosine+kinase+2+deficiency/9434" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HIES WITH ATYPICAL MYCOBACTERIOSIS, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="611521" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPER-IgE SYNDROME WITH ATYPICAL MYCOBACTERIOSIS, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="611521" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Susceptibility to infection due to TYK2 deficiency</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">IMD35</ElementValue>
                <XRef Type="MIM" ID="611521" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17514" />
                <XRef ID="17514" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="331226" DB="Orphanet" />
              <XRef ID="C1969086" DB="MedGen" />
              <XRef ID="MONDO:0012682" DB="MONDO" />
              <XRef Type="MIM" ID="611521" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="501110" SubmissionDate="2016-04-14" DateLastUpdated="2015-10-11" DateCreated="2015-10-11">
        <ClinVarSubmissionID localKey="NM_003331.4:c.209_212delGCTT|OMIM:611521" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000267549" DateUpdated="2015-10-11" DateCreated="2015-10-11" Type="SCV" Version="1" SubmitterName="Soonchunhyang University Bucheon Hospital, Soonchunhyang University Medical Center" OrgID="505765" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-03-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17088085</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>East Asian</Ethnicity>
              <GeographicOrigin>South Korean</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">40</Age>
              <Age Type="maximum" age_unit="years">69</Age>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>reference population</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TYK2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003331.4:c.209_212delGCTT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="611521" Type="MIM" />
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="34476" SubmissionDate="2018-08-31" DateLastUpdated="2018-09-03" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="176941.0001_IMMUNODEFICIENCY 35" title="TYK2, 4-BP DEL, 550GCTT_IMMUNODEFICIENCY 35" />
        <ClinVarAccession Accession="SCV000034476" DateUpdated="2018-09-03" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2006-11-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 22-year-old Japanese male with primary immunodeficiency-35 (IMD35; 611521), Minegishi et al. (2006) identified a homozygous deletion of GCTT at nucleotide 550 in the TYK2 gene, resulting in a frameshift and premature termination of the protein at amino acid 90. Immunoblot analysis detected no TYK2 protein in the patient's T cells. Both of the patient's parents, who were healthy, were heterozygous for the TYK2 mutation. Introduction of wildtype TYK2 into the patient's T cells rescued their cytokine signaling defects. The patient had characteristic features of both autosomal recessive hyper-IgE syndrome (HIES; 243700) and atypical mycobacteriosis (see 209950). Minegishi et al. (2006) concluded that TYK2 deficiency is a primary immunodeficiency displaying the phenotype of the autosomal recessive HIES accompanied by susceptibility to intracellular bacterial infection.</Attribute>
              <Citation>
                <ID Source="PubMed">17088085</ID>
              </Citation>
              <XRef DB="OMIM" ID="611521" Type="MIM" />
              <XRef DB="OMIM" ID="243700" Type="MIM" />
              <XRef DB="OMIM" ID="209950" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TYK2" />
          </GeneList>
          <Name>TYK2, 4-BP DEL, 550GCTT</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">4-BP DEL, 550GCTT</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="176941.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">IMMUNODEFICIENCY 35</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1203962" SubmissionDate="2019-01-29" DateLastUpdated="2017-12-19" DateCreated="2017-12-19">
        <ClinVarSubmissionID localKey="GDX:702533|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000617554" DateUpdated="2017-12-19" DateCreated="2017-12-19" Type="SCV" Version="2" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-10-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.209_212delGCTT variant in the TYK2 gene has been reported previously in the homozygous state in an individual with hyper-IgE syndrome (Minegishi et al., 2006). The c.209_212delGCTT variant causes a frameshift starting with codon Cysteine 70, changes this amino acid to a Serine residue, and creates a premature Stop codon at position 21 of the new reading frame, denoted p.Cys70SerfsX21. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The c.209_212delGCTT variant is observed in 12/17248 (0.07%) alleles, although not in the homozygous state, from individuals of East Asian background, in large population cohorts (Lek et al., 2016). We interpret c.209_212delGCTT as a pathogenic variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TYK2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003331.4:c.209_212delGCTT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6132659" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="4951305|MedGen:C1969086" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003442657" DateUpdated="2024-02-14" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22402565</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26304966</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29725107</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Cys70Serfs*21) in the TYK2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TYK2 are known to be pathogenic (PMID: 22402565, 26304966). This variant is present in population databases (rs770927552, gnomAD 0.07%). This premature translational stop signal has been observed in individual(s) with mendelian susceptibility to mycobacterial disease (PMID: 29725107). ClinVar contains an entry for this variant (Variation ID: 225508). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TYK2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.10479076_10479079del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1969086" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="34476" TraitType="Disease" MappingType="Name" MappingValue="IMMUNODEFICIENCY 35" MappingRef="Preferred">
        <MedGen CUI="C1969086" Name="Immunodeficiency 35" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1203962" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="501110" TraitType="Disease" MappingType="XRef" MappingValue="611521" MappingRef="OMIM">
        <MedGen CUI="C1969086" Name="Immunodeficiency 35" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6132659" TraitType="Disease" MappingType="XRef" MappingValue="C1969086" MappingRef="MedGen">
        <MedGen CUI="C1969086" Name="Immunodeficiency 35" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

